Cited by 181
The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer
Labbaye, Catherine, Testa, Ugo·2012·Journal of Hematology & Oncology
DOI 10.1186/1756-8722-5-13PMC PMC3342163
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Crossref · 10.1186/1756-8722-5-13
Cites
2 of 2 references verified0 citation errors · 0 not checkable
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A G/C polymorphism in the miR-146a locus is associated with papillary thyroid carcinoma (PTC) progression.
“In other examples, a G/C polymorphism in the miR‐146a locus, associated with papillary thyroid carcinoma (PTC) progression, alters the sequence of miR‐146a* (3p) strand, and likely leads to changes in target repression, contributing to PTC (Jazdzewski et al., 2009; Labbaye & Testa, 2012), (Table 1).”
From microRNA strand selection: Unwinding the rules (2021) · cites this paper as Labbaye & Testa, 2012
The G/C polymorphism alters the sequence of miR-146a* (3p) strand and likely leads to changes in target repression, contributing to PTC.
“alters the sequence of miR‐146a* (3p) strand, and likely leads to changes in target repression, contributing to PTC (Jazdzewski et al., 2009; Labbaye & Testa, 2012), (Table 1).”
From microRNA strand selection: Unwinding the rules (2021) · cites this paper as Labbaye & Testa, 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317 · see citing works
Macrophage development from HSCs requires PU.1-coordinated microRNA expression
Ghani, S., Riemke, P., Schönheit, J., Lenze, D., Stumm, J., Hoogenkamp, M., Lagendijk, A., Heinz, S., Bonifer, C., Bakkers, J., et al. (2011) · Blood · doi:10.1182/blood-2011-02-335141 · Cited by 123 · see citing works
Flagged first, then by citations
Research works printed but not linked: 58
- Thomson JM Newman M Parker JS Morin-Kensicki EM Wright T Hammond SM Extensive post-transcriptional regulation of microRNAs and its implications for cancer Genes Dev 2006 20 2202 2207 10.1101/gad.1444406 16882971 PMC1553203 · DOI · Paper page
- Hou J Wang P Liu L Liu X Ma F An H Wang Z Cao X MicroRNA-146a feedback inhibits RIG-1-dependent type I IFN production in macrophage by targeting TRAF6, IRAK1 and IRAK2 J Immunol 2009 183 2150 2158 10.4049/jimmunol.0900707 19596990 · DOI · Paper page
- Perry MM Maschos SA Williams AE Shapard NJ Larner-Svensson H Lindsay MA Rapid changes in microRNA-146a expression negatively regulate the IL-1β-induced inflammatory response in human lung alveolar epithelial cells J Immunol 2008 180 5689 5698 18390754 PMC2639646
- Rom S Rom I Passiatore G Pacifici M Radhakrishnan S Del Valle L Pina-Oveido S Khalili K Eletto D Peruzzi F CCL8/MCP-2 is a target for miR-146a in HIV1-infected human microglial cells FASEB J 2010 24 2292 2300 10.1096/fj.09-143503 20181935 PMC2887261 · DOI
- Curtale G Citarella F Carissimi C Goldoni M Carussi N Fulci V Franceschini D Meloni F Barnaba V Macino G An emerging player in the adptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes Blood 2010 115 265 273 10.1182/blood-2009-06-225987 19965651 · DOI
- Hurst DR Edmonds MD Scott GK Benz CC Vaidja KS Welch DR Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis Cancer Res 2009 69 1279 1283 10.1158/0008-5472.CAN-08-3559 19190326 PMC2754225 · DOI
- Li Y VandenBoom T II Wang Z Kong D Ali S Philip P Sarkar F miR-146a suppresses invasion of pancreatic cancer cells Cancer Res 2010 70 1486 1495 10.1158/0008-5472.CAN-09-2792 20124483 PMC2978025 · DOI
- Kogo R Mimori K Tanaka F Komune S Mori M Clinical significance of miR-146a in gastric cancer cases Clin Cancer Res 2011 17 4277 4284 10.1158/1078-0432.CCR-10-2866 21632853 · DOI
- Lin SL Chiang A Chang D Ying SY Loss of miR-146a function in hormone-refractory prostate cancer RNA 2008 14 417 424 10.1261/rna.874808 18174313 PMC2248249 · DOI
- Mei J Bacho R Zhang CL MicroRNA-146a inhibits glioma development by targeting Notch1 Mol Cell Biol 2011 31 3584 3592 10.1128/MCB.05821-11 21730286 PMC3165557 · DOI
- Labbaye C Spinello I Quaranta MT Pelosi E Pasquini L Petrucci E Biffoni M Nuzzolo ER Billi M Foà R Brunetti E Grignani F Testa U Peschle C A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis Nat Cell Biol 2008 10 788 800 10.1038/ncb1741 18568019 · DOI
- Sun S Zheng B Han M Fang X Li H Miao S Su M Han Y Shi H Wen JK miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation EMBO Rep 2011 12 56 62 10.1038/embor.2010.172 21109779 PMC3024123 · DOI
- Bhamik D Scott GK Schokrpur S Patil CK Campisi J Benz CC Expression of microRNA-146 suppresses NF-kB activity with reduction of metastatic potential in breast cancer cells Oncogene 2008 27 5643 5647 10.1038/onc.2008.171 18504431 PMC2811234 · DOI
- Horie T Ono K Nishi H Nagao K Kinoshita M Watanabe S Kuwabara Y Nakashima Y Takanabe-Mori R Nishi E Hasagawa K Kita T Kimura T Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuroregulin-ErbB pathway Card Res 2010 87 656 664 10.1093/cvr/cvq148 PMC2920811 20495188 · DOI
- Punji V Matta H Schamus S Tamewitz A Anyang B Chaudhary PM Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a Oncogene 2010 29 1835 1844 10.1038/onc.2009.460 20023696 PMC2845732 · DOI
- Lu LF Boldin MP Chaudry A Taganov KD Hanada T Yoshimura A Baltimore D Rudensky AK Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses Cell 2010 142 914 929 10.1016/j.cell.2010.08.012 20850013 PMC3049116 · DOI
- Nahid MA Paulei KM Satoh M Chan EKL miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity J Biol Chem 2009 50 34590 34599 19840932 PMC2787321
- Nahid MA Satoh M Chan EK Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling J Immunol 2011 186 1723 1734 10.4049/jimmunol.1002311 21178010 PMC3608687 · DOI
- Jurkin J Schichl YM Koeffel R Bauer T Richter S Konradi S Gesslbauer B Strobl H miR-146a is differentially expressed by myeloid dendritic cell subsets and desensitizes cells to TLR2-dependent activation J Immunol 2010 184 4955 4965 10.4049/jimmunol.0903021 20375304 · DOI
- Boldin MP Teganov KD Rao DJ Yang L Zhao JL Kalwani M Garcia-Flores Y Luong M Devrekanli A Xu J Sun G Tay J Lusley PS Baltimore D miR-146q is a significant brake on autoimmunity, myeloproliferation, and cancer in mice J Exp Med 2011 208 1189 1201 10.1084/jem.20101823 21555486 PMC3173243 · DOI · Paper page
- Zhao JL Rao DS Boldin MP Taganov KD O'Connell RM Baltimore D NF-kB dysregulation in microRNAa-deficient mice drives the development of myeloid malignancies Proc Natl Acad Sci USA 2011 108 9184 9189 10.1073/pnas.1105398108 21576471 PMC3107319 · DOI · Paper page
- Starczynowski DT Kuchenbauer F Wegrzyn J Rouhi A Petriv O Hansen CL Humphreis RK Karsan A MicroRNA-146a disrupts hematopoietic differentiation and survival Exp Hematol 2011 39 167 178 10.1016/j.exphem.2010.09.011 20933052 · DOI
- Garzon R Volinia S Liu CG Fernandez-Cymering C Palumbo T Pichiorri F Fabbri M Coombes K Alder H Nakamura T Flomenberg N Marcucci G Calin GA Kornblau SM Kantarjian H Bloomfield CD Andreef M Croce CM MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia Blood 2008 111 3183 3189 10.1182/blood-2007-07-098749 18187662 PMC2265455 · DOI
- Starczynowski DT Kukenbauer F Arigiropoulos B Sung S Morin R Muranyi A Hogge D Marra M Wells RA Buckenstein R Lan W Humphreis RK Korsan A Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype Nature Med 2010 16 49 58 10.1038/nm.2054 19898489 · DOI
- Opalinska JB Bersenev A Zhang Z Schumier AA Choi J Yao Y D'Souza J Tong W Weiss MJ MicroRNA expression in maturing megakaryocytes Blood 2010 116 e128 e138 10.1182/blood-2010-06-292920 20720187 PMC3012601 · DOI
- Edelstein LC Bray PF MicroRNAs in platelet production and activation Blood 2011 117 5289 5296 10.1182/blood-2011-01-292011 21364189 PMC3109704 · DOI
- Ryasen GW Starczynowski DT Deregulation of microRNA in myelodysplastic syndrome Leukemia 2012 26 13 22 10.1038/leu.2011.221 21852786 · DOI
- Budhu A Ji J Wang X The clinical potential of microRNAs J Hem Oncol 2010 3 37 10.1186/1756-8722-3-37 PMC2958878 20925959 · DOI
- He H Jazdsewski K Li W Liyanarachchi S Nagy R Volinia S Calin GA Liu C Franssila K Suster S Kloos RT Croce CM De la Chapelle A The role of microRNA genes in papillary thyroid carcinoma Proc Natl Acad Sci USA 2005 102 19075 19080 10.1073/pnas.0509603102 16365291 PMC1323209 · DOI
- Jazdewski K Murray EL Franssila K Jarkab B Schoenberg DR De La Chapelle A A common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma Proc Natl Acad Sci USA 2008 105 7269 7274 10.1073/pnas.0802682105 18474871 PMC2438239 · DOI · Paper page
- Jazdewski K Liyannrachchi S Swierniak M Pachucki J Ringel MD Jarzab B De La Chapelle A Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer Proc Natl Acad Sci 2009 106 1502 1505 10.1073/pnas.0812591106 19164563 PMC2635764 · DOI · Paper page
- De La Chapelle A Jazdewski K MicroRNA in thyroid cancer J Clin Endocrinol Metab 2011 96 3326 3336 10.1210/jc.2011-1004 21865360 PMC3410255 · DOI
- Pacifico F Crescenzi E Mellone S Iannetti A Pomino N Liguoro D Moscato F Grieco M Formisano S Leonardi A Nuclear factor- {kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a J Clin Endocrinol Metab 2010 95 1421 1430 10.1210/jc.2009-1128 20061417 · DOI
- Li L Chen XP Li Y MiR-146a and human disease Scand J Immunol 2010 71 227 231 10.1111/j.1365-3083.2010.02383.x 20384865 · DOI · Paper page
- Yu J Li A Hong SM Hruban RH Goggins M Micro RNA alterations of pancreatic intraepithelial neoplasms (PanINs) Cancer Res 2012 18 981 992 10.1158/1078-0432.CCR-11-2347 PMC3288338 22114139 · DOI
- Bao B Ali S Benerjee S Wang Z Logne F Azmi AS Kong D Ahmad A Li Y Padhye S Sarkar FH Curcumin analog CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating E2H2 expression Cancer Res 2011 72 335 345 22108826 PMC3792589
- Hou Z Xie L Yu L Qian X Liu B MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis Med Oncol 2011 in press 21347720
- Liu Z Xiao B Tang B Li B Zhu E Guo G Gu J Zhuang Y Liu X Ding H Zhao X Guo H Mao X Zou Q Up-regulated microRNA-146a negatively modulates Helicobactert pylori-induced inflammatory response in human gastric epithelial cells Microbes Infect 2010 12 854 863 10.1016/j.micinf.2010.06.002 20542134 · DOI
- Li N Xu X Xiao B Zhu ED Li BS Liu Z Tang B Zou QM Liang HP Maop XH H. pylori related proinflammatory cytokines contribute to the induction of miR-146a in human gastric epithelial cells Mol Biol Rep 2011 in press 21947847
- Bhaumik D Scott GK Schokrpur S Patil CK Campisi J Benz CC Expression of micro-RNA 146 suppresses NF-kB activity with reduction of metastatic potential in breast cancer cells Oncogene 2008 27 5643 5647 10.1038/onc.2008.171 18504431 PMC2811234 · DOI
- Lavon I Zrihan D Granit A Einstein O Fainstein N Cohen MA Zelikovitch Shoshan Y Spektor S Reubinoff BE Felig Y Geritz O Ben-Hur T Siegal T Glioma display a microRNA expression profile reminiscent of neural precursor cell Neurol Oncol 2010 12 422 433 PMC2940621 20406893
- Permuth-Wey J Thompson RC Burton Nabors L Olson JJ Browning JE Modden MH Ann Chen Y Egan KM A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma J Neuropharmacol 2011 105 639 646 PMC3217154 21744077
- Wang X Tang S Le SY Lu R Rader JS Meyers C Zheng ZM Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth PLoS One 2008 3 e2557 10.1371/journal.pone.0002557 18596939 PMC2438475 · DOI
- Visone R Rassenti LZ Veronese A Taccioli C Costinean S Aguda BD Volinia S Ferracin M Palatini J Balatti V Alder H Negrini M Kipps JJ Croce CM Karyotype-specific microRNA signature in chronic lymphocytic leukemia Blood 2009 114 3872 3879 10.1182/blood-2009-06-229211 19717645 PMC2773482 · DOI
- Garzon R Volinia S Liu CG Cymering CF Palumbo T Bloomfield C Andreef M Croce CM MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia Blood 2008 111 3183 3189 10.1182/blood-2007-07-098749 18187662 PMC2265455 · DOI
- Lutherborrow M Bryant A Jayaswal V Expression profiling of cytogenetically normal AML identifies microRNAs that target genes involved in monocytic differentiation Am J Hematol 2011 86 2 11 10.1002/ajh.21864 20981674 · DOI
- Spinello I Quaranta MT Riccioni R Riti V Pasquini L Boe A Pelosi E Vitale A Foà R Testa U Labbaye C Micro RNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias Blood Cancer Journal 2011 1 e26 10.1038/bcj.2011.24 PMC3255264 22829170 · DOI
- Starczynovski DT Morin R McPherson A Lam J Chafi R Wegzyn J Kuckenbauer F Hirst M Tohyama K Humphreis K Lam WL Marra M Karsan A Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations Blood 2011 117 595 607 10.1182/blood-2010-03-277012 20962326 · DOI
- Zhang H Wang HR Yang S Wang T Wang C Chen FY Targeting of Smad 4 links microRNA-146a to the TGFbeta pathway during retinoic acid induction in acute promyelocytic leukemia cell line Int J Hematol 2010 92 129 135 10.1007/s12185-010-0626-5 20577838 · DOI
- Votivova A Gronanova M Merkerova MD Belikova M Vasikova A Neuwirtova R Cernak J Differential expression of microRNAs in CD34+ cells of 5q- syndrome J Hemat Oncol 2011 4 1 10.1186/1756-8722-4-1 PMC3024999 21211043 · DOI
- Sachdeva M Zhu S Wu F p53 represses c-Myc through induction of the tumor suppressor miR-145 Proc Natl Acad Sci USA 2009 106 3207 3212 10.1073/pnas.0808042106 19202062 PMC2651330 · DOI
- Boultwood J Pellegatti A McKenzie AN Wainscoat JS Advances in the 5q- syndrome Blood 2010 116 5803 5811 10.1182/blood-2010-04-273771 20733155 · DOI
- Flamant S Ritchie W Guilhot J Holst J Bonnet ML Chomel JC Guilhot F Turhan A Rasko J Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia Haematologica 2010 95 1325 1333 10.3324/haematol.2009.020636 20460641 PMC2913081 · DOI
- Paik J Jang JY Jeon YK Kim WY Kim TM Heo DS Kim CW MicroRNA-146a downregulates NFkB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma Clin Cancer Res 2011 17 4761 4771 10.1158/1078-0432.CCR-11-0494 21610143 · DOI
- Pichler K Schneider G Grassmann R MicroRNA miR-146a and farther oncogenesis-related cellular microRNA are dysregulated in HTLV1-transformed T lymphocytes Retrovirology 2008 5 100 10.1186/1742-4690-5-100 19014482 PMC2628945 · DOI · Paper page
- Tomita M Tanaka Y Mori N MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells Int J Cancer 2010 20017139
- Motsch N Pfuhl T Marazek J Barth S Grasser FA Epstein-Barr virus-encoded latent membrane protein1 (LMP1) induces the expression of the cellular microRNA miR-146a RNA Biol 2007 4 131 137 10.4161/rna.4.3.5206 18347435 · DOI
- Cameron JE Yiu Q Fewell C Lacey M Mc Bride J Epstein-Barr virus latent membrane protein 1 induces cellular microRNA-146a, a modulator of lymphocyte signaling pathways J Virol 2008 82 1946 1958 10.1128/JVI.02136-07 18057241 PMC2258704 · DOI
Cited by
Sorted by citations
microRNA strand selection: Unwinding the rules
Medley, J. C., Panzade, G., & Zinovyeva, A. Y. (2021) · WIREs RNA · doi:10.1002/wrna.1627 · Cited by 225 · see citing works
Vergani, E., Dugo, M., Cossa, M., Frigerio, S., Di Guardo, L., Gallino, G., Mattavelli, I., Vergani, B., Lalli, L., Tamborini, E., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00601-1 · Cited by 39 · see citing works
- Authors
- Labbaye, C., & Testa, U.
- Venue
- Journal of Hematology & Oncology
- Published
- 2012-03-27
- Volume
- 5
- Issue
- 1
- ISSN
- 1756-8722
- PMC
- PMC3342163
- Cited by
- 181
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
